GeneralBullishBlockonomi · 4h ago7/10
📰
NewLimit Series C: Armstrong-Backed Longevity Startup Raises $435M
NewLimit, a longevity biotech startup backed by Neil Armstrong's family, raised $435M in Series C funding led by Founders Fund to advance epigenetic reprogramming therapies. The company plans to initiate first-in-human clinical trials for its lead liver cell regeneration program next year following recent breakthrough research results.